Publisher's Synopsis
Panorama investigates GlaxoSmithKline's suppression of the potentially deadly side effects of the antidepressent Seroxat/Paxil. Facing less-than-optimal results from clinical trials, the company hid the results and encouraged off-label prescriptions. UK regulators later found that the drug triples the risk of suicidal thoughts and behavior in depressed children.